Related Experiment Videos
[Calcium antagonists and ischemic heart disease]
Hidehiro Matsuoka1, Tsutomu Imaizumi
1Department of Internal Medicine III, Kurume University School of Medicine.
Clinical Calcium
|October 4, 2005
Summary
Long-acting calcium antagonists are effective and well-tolerated blood pressure medications. They may be crucial for managing ischemic heart disease due to their anti-atherogenic effects and proven clinical benefits.
Area of Science:
- Pharmacology
- Cardiology
- Vascular Biology
Context:
- Long-acting calcium antagonists exhibit diverse anti-atherogenic properties.
- These agents are recognized for their efficacy and tolerability in lowering blood pressure.
Purpose:
- To review the role of long-acting calcium antagonists in managing ischemic heart disease.
- To highlight their therapeutic potential based on clinical evidence.
Summary:
- Clinical trials demonstrate improved outcomes in coronary artery disease patients treated with these agents.
- Their anti-atherogenic effects contribute to their cardiovascular benefits.
Impact:
- Long-acting calcium antagonists show promise as a central therapeutic strategy for ischemic heart disease.
- Evidence supports their use in improving cardiovascular health and patient outcomes.